Compliances - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory filing where the company confirms to the depositories (NSDL/CDSL) that share certificates received for dematerialisation have been properly processed and the records updated within the prescribed time frame. Such certificates are typically submitted periodically as part of standard share transfer and demat-related compliance. No financial figures, transaction values, or material business information is disclosed in this filing.
This is a routine procedural compliance filing and has no direct impact on the company's financials, operations, or share price. Investors can ignore it for decision-making purposes.